Antidepressants: mechanism of action, toxicity and possible amelioration

@inproceedings{Gaur2017AntidepressantsMO,
  title={Antidepressants: mechanism of action, toxicity and possible amelioration},
  author={Khushboo Gaur and Balkishan Sharma},
  year={2017}
}
Depression being a state of sadness may be defined as a psychoneurotic disorder characterised by mental and functional activity sadness reduction in activity difficulty in thinking loss of concentration perturbations in appetite sleeping and feelings of dejection hopelessness and generation of suicidal tendencies It is a common and recurrent disorder causing significant morbidity and mortality worldwide The antidepressant compounds used against depression are reported to be used also for… 

Tables from this paper

Phytochemicals as Antidepressants

The present chapter illustrates recent advances in research concerning phytochemicals acting as antidepressants as they possess enormous antioxidant potential, easy availability, low cost, least toxicity, and high therapeutic potential.

Antidepressant Screening Demonstrated Non-Monotonic Responses to Amitriptyline, Amoxapine and Sertraline in Locomotor Activity Assay in Larval Zebrafish

Findings indicate that these antidepressants might share a common mechanism responsible for their effects on zebrafish larval locomotor activity although there were some differences in potency of these effects.

Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants

An overview of structural changes in the brain during depression; different neurobiological theories and novel drug development; strategy of augmentation with combinatorial therapy; receptors and targets of actions of antidepressants; and involvement of key signaling factors in the regulation of depression, pharmacology, metabolism, and the underlying principles involved in displaying how the application of antidepressants modulates the structure and function of the brain are presented.

Factors inducing depression as effective tool in therapy

Depression being a psychological disorder is known to cause morbidity and mortality of the concerned individual globally. According to an estimate from the World Health Organisation (WHO), about 57

DEPRESSION: AN OVERVIEW IN THE PATHOPHYSIOLOGY AND TREATMENT

This hypothesis can help to elucidate the surprisingly positive results found in the treatment of depression with lactate shuttle and normalise depression-related brain changes.

Neurobehavioural Mechanism of Antidepressant Effect of Methanol Stem Bark Extract of Adansonia digitata (Linn) in Tail Suspension Test in Mice

It is concluded that the methanol stem bark extract of Adansonia digitata may possess antidepressant effect and its mechanism may involve multiple pathways.

Efficacy and Safety of Escitalopram Oral Drops to Treat Major Depressive Disorder and Generalized Anxiety Disorder in Adolescent, Adult and Geriatric Patients: A Prospective Multicenter Observational Study in Pakistan

Escitalopram oral drops are found effective and tolerable in reducing both anxiety and depression over the duration of study in all age groups, including adolescents, adults, and geriatrics.

Pharmacological & Non-Pharmacological Interventions For Stroke Induced Depression: A Review

Different treatment options available for post stroke depression include Antidepressants, psychotherapy, surgical therapy, Transcranial magnetic stimulation, acupuncture, music therapy, and more.

Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder

MDEs responded to vortioxetine similarly to OADs by improving in depression, general psychopathology, anxiety, suicidal thinking, and quality-of-life, independently from SUD comorbidity.

References

SHOWING 1-10 OF 88 REFERENCES

The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.

The findings that relapse during treatment is specific to the type of treatment and type of depletion, that neither SD or CD produced an increase in clinical depression in healthy controls or depressed patients off medication, and that recovered patients off medications have a return of symptoms following SD, forces a major revision of the current monoamine theories of depression.

Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials.

The authors have concluded that tianeptine is effective in depressive disorders as shown both by depression rating scales and subjective impressions of treated patients, and improvement increases regularly with time.

Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression

Current data support a decreased frequency of suicidal ideation with all antidepressants, including selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs), which provides fluoxetine with an overall superior therapeutic profile.

Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.

  • S. Stahl
  • Psychology, Biology
    The Journal of clinical psychiatry
  • 1998
The selective norepinephrine and dopamine reuptake inhibitor bupropion defines a novel class of antidepressant that has no direct actions on the serotonin system.

Modifications of the Serotonin System by Antidepressant Treatments: Implications for the Therapeutic Response in Major Depression

Results of electrophysiological single-cell recording studies suggest that most, if not all, types of antidepressant treatments increase 5-hydroxytryptamine (5-HT) neurotransmission. Tricyclic

Drug Treatment of Depression in the 1990s

The most important progress in the past 10 years has been the development of compounds which possess markedly reduced binding capacities at receptor sites not linked to their antidepressive actions.

Evidences for the involvement of monoaminergic and GABAergic systems in antidepressant-like activity of garlic extract in mice

Garlic extract showed significant antidepressant-like activity probably by inhibiting MAO-A andMAO-B levels and through interaction with adrenergic, dopaminergic, serotonergic and GABAergic systems.

Position of tianeptine among antidepressive chemotherapies.

Tianeptine can be classified among the mid-position antidepressants, and has no anticholinergic effect and no cardiovascular effect, and appears to be neither stimulating nor sedative.

Antidepressant activity of aqueous extract of fruits of Emblica officinalis in mice.

Both imipramine and EO significantly reduced the duration of immobility in both experimental models as compared to the animals in the control group, indicating the potential for use of EO as an adjuvant in the treatment of depression.
...